13-valent pneumococcal polysaccharide conjugate vaccine (Jiangsu Kunli Biopharmaceutical)

N/A

Report date: 2025/10/28 17:51:01

Base Information

Drug Name13-valent pneumococcal polysaccharide conjugate vaccine (Jiangsu Kunli Biopharmaceutical)
Drug Alias NameStreptococcus pneumoniae vaccine (polysaccharide conjugated, 13-valent) (Jiangsu Kunli Biopharmaceltical)polysaccharide conjugated vaccine (13-valent, Streptococcus pneumoniae infection) (Jiangsu Kunli Biopharmaceltical)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Kunli Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Kunli Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A